Hikma Pharmaceuticals USA Inc. Extends Voluntary Recall of Ketorolac Tromethamine Injection Vials

Company Announcement Date: March 04, 2020

FDA Publish Date: March 05, 2020

Product Type: Drugs Reason for Announcement: Potential Presence of Small Particulates

Company Name: Hikma Pharmaceuticals USA Inc.

Brand Name: West-Ward Product Description: Ketorolac Tromethamine Injection, USP 30mg/mL, 1 mL Vial